搜尋結果
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 2 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
Bayer Menopause Drug Shows Positive Result in Late-Stage Trials
Bloomberg· 7 日前Bayer AG said a positive outcome from twin late-stage trials on a promising experimental menopa ...
Will 6G deliver where ‘overhyped’ 5G didn’t? An expert sees a holographic future
South China Morning Post· 6 日前When mobile telecommunications made the leap from 2G to 3G, users were no longer limited to ...
Shenzhou-18 crew prepares for material extravehicular exposure experiments
Bastillepost· 6 日前The China Manned Space Agency on Saturday released a video of the astronauts' work over the ...
Victor Lim Seaward and Louis Appleby’s Exhibitions Are Currently on View at THE SHOPHOUSE
HYPEBEAST· 4 日前The show’s title derives from a melancholic poem by Song Dynasty poet, Li Qingzhao, which sets ...
Up 165% This Year, Will Dyne Therapeutics Continue Its Stellar Run?
Forbes· 2 日前: DYN), a biotechnology company focused on advancing genetically driven muscle diseases ...
Researchers refine their understanding of ice surface premelting
China Daily· 1 日前Ice surface is an important medium for a variety of natural phenomena and atmospheric reactions, which has significant effects ...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 日前GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 ...
Council Post: The Philanthropic Choice Between Innovation And Stagnation
Forbes· 3 日前Philanthropy was built backward—it started with creating systems, strategies and outcomes ...
Biogen to Pay Up to $1.8 Billion for Immune Drug Developer
Bloomberg· 2 日前Have a confidential tip for our reporters? Biogen Inc. agreed to acquire Human Immunology ...